Answers are grounded in this paper and cite their sources.
Alternative dosing strategies may materially reduce the population health impacts of cancer care by reducing environmental impact. Regulatory decision making and health technology assessments should consider a treatment's environmental and population health impacts. Clinical trials of alternative dosing strategies are justified on the basis of environmental and population health impacts.
No takes yet. Share an insight, caveat, or question.
Jacobson et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: